Neurodegenerative Research

At Lilly, we want to continue developing and making medicines to meet the needs of people with neurodegenerative diseases. A neurodegenerative disease causes the nerves in your brain and spine to stop working the right way over time.
Through clinical research we are looking to find potential medicines that may help treat or slow down the development of many neurodegenerative conditions. These include:

  • Alzheimer’s disease
  • Frontotemporal dementia and other types of dementia and memory loss
  • Parkinson’s disease
  • Gaucher disease

By taking part in a clinical research study, you can help to make a difference. Click here to view neurodegenerative disease trials.

About Our Research

Lilly was founded in 1876 with the goal of making new high-quality medicines for the people that need them. The company’s aim is the same today! We work with people who take our medicines, healthcare workers who prescribe our medicines, our employees who make our medicines, and potential patients and caregivers in communities around the world to create the best possible research experience that we can.

Neurodegenerative Diseases Research Areas

Neurodegenerative conditions can involve problems with memory, thinking, movement and coordination. They are usually progressive, which means they get worse over time, and there are no cures currently available.
With clinical research, we can get more information about how these diseases start and get worse. This helps us find ways to potentially prevent, better manage, and treat the conditions.
Click on the conditions below to learn more about neurodegenerative diseases that we are carrying out clinical research studies for. You can also view neurodegenerative disease clinical trials or to learn more about Alzheimer’s disease and research in this area, visit our page about Alzheimer’s Disease.

Graphic of 3 puzzle pieces.

Lilly Trial Connect

Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Find a Trial

Conditions: Alzheimer's disease
Drugs: donanemab
Age
60 - 85 years
Phase
III
Conditions: Alzheimer's disease
Trial Name
TRAILRUNNER-ALZ 1
Drugs: Remternetug (LY3372993)
Age
60 - 85 years
Phase
III
Conditions: Alzheimer's Disease
Trial Name
TRAILBLAZER-ALZ 3
Drugs: Donanemab, LY3002813
Age
65 - 80 years
Phase
III
Conditions: Alzheimer's disease
Drugs: donanemab
Age
60 - 85 years
Phase
III
Conditions: Gaucher Disease, Type 1
Trial Name
PROCEED
Drugs: LY3884961
Age
18 - 65 years
Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Not the right fit? Sign up to receive Lilly Trial Alerts to find out about new trials.

Learning Center

Two adults working together on a puzzle book and having fun. They are sitting outside.

Test Your Knowledge

Test your knowledge to see how much you know about clinical trials and neurodegenerative disease research. Answer these 10 questions to enhance your knowledge, or you might find out you are already an expert! 

Explore Research Areas

Lilly is committed to discovering and developing potential new medicines for people living with neurodegenerative conditions.